Meeting NewsPerspective

Novel blood tests could improve cancer detection

November 14, 2019
Two novel blood assays demonstrated efficacy in detecting various cancer types at different disease stages, according to results of two studies…
FDA News

FDA warns Dollar Tree regarding ‘potentially unsafe’ drugs

November 14, 2019
The FDA has sent a warning letter to Greenbrier International, Inc., doing business as Dollar Tree, for receiving over-the-counter drugs made by…
In the Journals

Classifier predicts radiotherapy benefit, locoregional recurrence risk in early-stage breast cancer

November 14, 2019
A newly developed clinico-genomic classifier identified which women with early-stage breast cancer would benefit substantially from adjuvant…
In the Journals

Pembrolizumab induces durable responses in relapsed, refractory primary mediastinal large B-cell lymphoma

November 14, 2019
Pembrolizumab appeared to be associated with high response rates, durable activity and manageable toxicity among patients with relapsed or refractory…
Meeting News

‘Stop and think’ each time you use social media professionally

November 14, 2019
ATLANTA — Because social media guidelines at the institution, practice setting and professional organizations are often vague or open to…
In the JournalsPerspective

Secondary surgery does not prolong survival in recurrent ovarian cancer

November 13, 2019
Secondary surgical cytoreduction followed by chemotherapy did not extend OS compared with chemotherapy alone among women with platinum-sensitive…
In the Journals

Oral blood cancer drug may worsen cardiometabolic health

November 13, 2019
An oral chemotherapy treatment used to treat myeloproliferative neoplasms is associated with substantial weight gain and increased systolic blood…
Meeting News

Sitravatinib plus nivolumab safe, active in advanced urothelial carcinoma

November 13, 2019
NATIONAL HARBOR, Md. — The combination of sitravatinib and nivolumab induced encouraging clinical activity among patients with advanced…
In the JournalsPerspective

‘Running medicine’ improves health

November 13, 2019
“Running medicine” events that combined several types of exercise and community-building events improved participants’ physical and…
In the Journals

Melanoma rates decline among US adolescents, young adults

November 13, 2019
Incidence of invasive melanoma decreased among adolescents and young adults in the United States between 2006 and 2015, according to results of a…
FDA News

FDA fast tracks nanatinostat combination for Epstein-Barr virus-associated lymphoma

November 13, 2019
The FDA granted fast track designation to nanatinostat in combination with valganciclovir for the treatment of relapsed or refractory Epstein-Barr…

Trial of KD025 for chronic GVHD meets primary endpoint at interim analysis

November 12, 2019
A pivotal trial designed to assess KD025 for patients with pretreated chronic graft-versus-host disease met its primary endpoint of overall response…
In the Journals

Addition of panitumumab to FOLFOXIRI improves response rates in colorectal cancer subtype

November 12, 2019
Adding panitumumab to FOLFOXIRI chemotherapy improved rates of overall response and secondary resection of metastases among patients with RAS
Feature

Direct-to-consumer genetic tests may provide false assurance to patients at risk

November 12, 2019
The advent of direct-to-consumer

GO2 Foundation for Lung Cancer presents awards

November 12, 2019
GO2 Foundation for Lung Cancer presented several awards at its 14th annual Simply the Best Dinner and Gala. Roy S. Herbst, MD, PhD, received…
Feature

Penn program addresses ‘barriers and bias’ unique to women in oncology

November 11, 2019
PHILADELPHIA — More than 40% of U.S. medical students and physicians-in-training over the past 2 decades have been female. However, women…
In the Journals

Antidepressant use linked to slightly increased risk for subdural hematoma

November 11, 2019
Use of selective and nonselective serotonin reuptake inhibitors appeared associated with a small increased risk for subdural hematoma, according to…
FDA News

FDA grants priority review, breakthrough therapy designation to Opdivo-Yervoy combination for HCC

November 11, 2019
The FDA granted the combination of nivolumab and ipilimumab priority review and breakthrough therapy designation for the treatment of patients with…

Avelumab maintenance fails to extend OS in advanced gastric, gastroesophageal junction cancers

November 11, 2019
A randomized phase 3 trial designed to evaluate avelumab as first-line maintenance therapy for patients with unresectable, locally advanced or…
Meeting News

Novel bispecific immune cell engager safe, clinically beneficial in HER2-positive tumors

November 10, 2019
NATIONAL HARBOR, Md. — An investigational bispecific T-cell engager appeared safe and demonstrated some clinical activity among patients with…